5 Mar 2014 14:38
Omega Diagnostics Group PLC
("Omega" or the "Company")
Director/PDMR Shareholding
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that the following Directors of the Company have today purchased ordinary shares of 4p each in the Company as follows:
Name | No. of shares | Price per share |
Andrew Shepherd | 18,000 | 29.935 pence |
Jag Grewal | 19,691 | 30.25 pence |
Following this transaction, Mr Shepherd's total beneficial holding has increased to 2,677,206 ordinary shares representing 2.46% of the total voting rights of the Company and Mr Grewal's total beneficial holding has increased to 49,103 ordinary shares representing 0.05% of the total voting rights of the Company.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Andrew Shepherd, Chief Executive | www.omegadiagnostics.com |
Kieron Harbinson, Group Finance Director | |
Jag Grewal, Group Sales and Marketing Director | |
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/Christopher Raggett (Corporate Finance) | |
Stephen Norcross/Mia Gardner (Corporate Broking) | |
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
ODX.L (ODX)